AI assistant
CVS HEALTH Corp — Director's Dealing 2021
Feb 8, 2021
29875_dirs_2021-02-08_04e9bbfd-b1b7-4ffb-80c3-fad2c8ec99c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-02-01
Reporting Person: Finke Daniel P (EVP/Pres, Health Care Benefits)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9799.1519 | Direct |
| Common Stock (restricted) | 11072 | Direct |
| Common Stock (restricted) | 7687 | Direct |
| Common Stock (restricted) | 3023.1519 | Direct |
| Common Stock (restricted) | 24425 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $54.19 | 2029-04-01 | Common Stock (64642) | Direct | |
| Stock Option | $58.34 | 2030-04-01 | Common Stock (54332) | Direct | |
| Stock Option | $52.37 | 2029-05-31 | Common Stock (28640) | Direct |
Footnotes
F1: Consists of Restricted Stock Units ("RSUs") awarded pursuant to Issuer's Aetna Inc. 2010 Stock Incentive Plan ("SIP"). Restrictions on remaining RSUs lapse in three equal installments, commencing 4/1/2021.
F2: Consists of RSUs that were converted from Aetna Performance Stock Units ("PSUs"), pursuant to the CVS Health-Aetna Merger Agreement, and that vest on 3/2/2021.
F3: Consists of matching RSUs awarded pursuant to Issuer's Partnership Equity Program, a sub-plan under its SIP. Restrictions lapse on 5/31/2024.
F4: Consists of RSUs awarded pursuant to Issuer's SIP. Restrictions lapse in four equal installments, commencing 4/1/2021.
F5: Option became exercisable in four equal annual installments, beginning on 4/1/2020.
F6: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
F7: Option becomes exercisable in three equal installments, commencing 5/31/2022.